![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, June 12, 2022 2:59:56 PM
6/11/22, 06:54 PM
- Yup an we are about to enter into clinical trials on that Check Point Inhibitor NR2F6 any day. It could happen on Monday! Matter if it's this week or next, one way or another, it's going to happen soon! When that happens there will be an immediate fundamental shift in the valuation of this company that will push the pps upward. The fact that Dr. Koos has submitted the IND for NR2F6 to develop an mRNA vaccine for treating pancreatic and colon cancer, means he must have completed Pre-Clinical for that to happen for reason the results of Pre-Clinical are looked at closely before granting approval to proceed to Phase
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM